ARTICLE | Financial News
InMed proposes follow-on
April 28, 2017 7:00 PM UTC
On April 21, cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) proposed a follow-on underwritten by Canaccord Genuity and Roth Capital Partners....
BCIQ Company Profiles